1. Home
  2. ACON vs VTAK Comparison

ACON vs VTAK Comparison

Compare ACON & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACON
  • VTAK
  • Stock Information
  • Founded
  • ACON 2008
  • VTAK 2002
  • Country
  • ACON United States
  • VTAK United States
  • Employees
  • ACON N/A
  • VTAK N/A
  • Industry
  • ACON Retail: Computer Software & Peripheral Equipment
  • VTAK Medical/Dental Instruments
  • Sector
  • ACON Technology
  • VTAK Health Care
  • Exchange
  • ACON Nasdaq
  • VTAK Nasdaq
  • Market Cap
  • ACON 977.9K
  • VTAK 1.4M
  • IPO Year
  • ACON 2022
  • VTAK 2018
  • Fundamental
  • Price
  • ACON $0.04
  • VTAK $0.46
  • Analyst Decision
  • ACON Buy
  • VTAK
  • Analyst Count
  • ACON 2
  • VTAK 0
  • Target Price
  • ACON $1.30
  • VTAK N/A
  • AVG Volume (30 Days)
  • ACON 46.2M
  • VTAK 734.4K
  • Earning Date
  • ACON 11-14-2024
  • VTAK 11-13-2024
  • Dividend Yield
  • ACON N/A
  • VTAK N/A
  • EPS Growth
  • ACON N/A
  • VTAK N/A
  • EPS
  • ACON N/A
  • VTAK N/A
  • Revenue
  • ACON $49,289.00
  • VTAK $399,000.00
  • Revenue This Year
  • ACON N/A
  • VTAK $38.46
  • Revenue Next Year
  • ACON $186.36
  • VTAK $533.33
  • P/E Ratio
  • ACON N/A
  • VTAK N/A
  • Revenue Growth
  • ACON N/A
  • VTAK 27.07
  • 52 Week Low
  • ACON $0.03
  • VTAK $0.31
  • 52 Week High
  • ACON $3.85
  • VTAK $4.10
  • Technical
  • Relative Strength Index (RSI)
  • ACON 34.57
  • VTAK 51.41
  • Support Level
  • ACON $0.03
  • VTAK $0.40
  • Resistance Level
  • ACON $0.05
  • VTAK $0.51
  • Average True Range (ATR)
  • ACON 0.04
  • VTAK 0.07
  • MACD
  • ACON -0.01
  • VTAK -0.00
  • Stochastic Oscillator
  • ACON 2.63
  • VTAK 34.35

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System) which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Share on Social Networks: